Department of Clinical Pharmacology Uni... Publications

Clinical Trial Review Systematic Review Meta-Analysis Books and Documents Randomized Controlled Trial

1 results match your criteria: "Department of Clinical Pharmacology University Clinic Basel Basel Switzerland.[Affiliation]"

Page 1 of 1

Complete hematological and major molecular response through treatment with low-dose Interferon alpha 2a in high-risk polycythemia vera patient: a case report.

Clin Case Rep

October 2021

Department of Clinical Pharmacology University Clinic Basel Basel Switzerland.

Christoph Driessen Christoph Noppen Georg Boonen Juergen Drewe

Low-dose interferon-α 2a treatment may be considered as an alternative to cytoreductive therapy with hydroxyurea or regularly dosed interferon in high-risk polycythemia vera patients.

View Article and Find Full Text PDF

Similar Publications

Geographic Location

Publish Date

Article Type

Complete hematological and major molecular response through treatment with low-dose Interferon alpha 2a in high-risk polycythemia vera patient: a case report.